Health
Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo – News-Medical.Net
Researchers have developed a stable and ultrapotent homotrimeric Pittsburgh inhalable Nanobody 21 (PiN-21) against SARS-CoV-2 infection in Syrian hamsters. They…
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), are being administered worldwide. A successful, safe and targeted therapeutic drug to treat this infection is yet to emerge.
Convalescent plasma, repurposed antivirals, neutralizing monoclonal antibodies, and highly selected nanobodies (Nbs) and multivalent forms are some of the innovative therapeutics tried against this virus.
However, these attempts to arrive…
-
Noosa News17 hours agoTallest tower outside CBD approved for construction at 205 metres
-
Noosa News22 hours agoTrucking company penalised for refusing to pay unfairly sacked worker
-
Noosa News18 hours agoFarmgate Backpackers leads with integrity amid industry challenges
-
General24 hours agoVacherot becomes lowest-ranked ATP Masters winner after defeating his cousin Rinderknech in Shanghai